drugset / Trial / NCT00895128
Study of Erlotinib in Combination With Dasatinib
NaSingle-groupOpen-labelTreatment
Summary
The goal of this clinical research study is to find the highest tolerable dose of Tarceva (erlotinib hydrochloride) that can be given in combination with Sprycel (dasatinib). The safety of this drug combination will also be studied.
Timeline
- Start
- 2009-04
- Primary completion
- 2015-07
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Erlotinib | Small molecule | 50 mg | Oral |
| Subject | Erlotinib | Small molecule | 100 mg | Oral |
| Subject | dasatinib anhydrous | Small molecule | 50 mg | Oral |